150 results
Page 6 of 8
424B3
qrnehypm6klpi l6
22 Jun 18
Prospectus supplement
4:24pm
S-1MEF
EX-8.1
xtvffsza
22 Jun 18
Registration of additional securities for an S-1
4:05pm
424B4
7qvrfsexnvjqa xw5u
15 Jun 18
Prospectus supplement with pricing info
12:26pm
10-KT
kw8wgc6 hwhom9i2
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
0bkyk82k vx1
24 Apr 17
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
g83i0z1h9bi3q3lkx
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
424B5
ffmrhp
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
rfhr0
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-10.1
hp36v5fwb4066y4n
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am